semaglutide supply shortage news november 2025 As GLP-1 drugs become more widely available, they are reshaping how Americans approach weight management and chronic disease prevention. The trend points to a sustained shift in public health, carried forward by The Wild East of semaglutide

Scientists from Pune have reported a gene-silencing strategy that can drive effective tumor inhibition in breast cancer, highlighting its potential as next-generation precision nanomedicine

Weight regain after stopping GLP-1 medications is well-documented and expected

CKR has received research funding from Merck, Eli Lilly, Sanofi, AstraZeneca and Novartis, and participated in advisory boards for Allergan and Glyscend

In particular, this second subtype is associated with more unfavorable clinical features, an enrichment in malignant signaling pathways and a tumor-friendly immune microenvironment compared to the first

Sulphur in Plants